TELA BioTELA +2.66%52 Market Cap is $33.57 Mil as of Jun. 30, 2026. GuruFocus rates TELA with a GF Score™ of 52/100 and a GF Value™ of $1.67 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 867 Medical Devices & Instruments companies, TELA Bio ranks worse than 68.97% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). TELA Bio's share price for the quarter that ended in Mar. 2026 was $0.62. TELA Bio's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 44.77 Mil. Therefore, TELA Bio's market cap for the quarter that ended in Mar. 2026 was $27.75 Mil.
TELA Bio's quarterly market cap
declined
from Sep. 2025 ($60.11 Mil) to Dec. 2025 ($52.55 Mil) and
declined
from Dec. 2025 ($52.55 Mil) to Mar. 2026 ($27.75 Mil).
TELA Bio's annual market cap
declined
from Dec. 2023 ($162.16 Mil) to Dec. 2024 ($118.98 Mil) and
declined
from Dec. 2024 ($118.98 Mil) to Dec. 2025 ($52.55 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. TELA Bio's Enterprise Value for Today is $50.43 Mil.
TELA Bio (NAS:TELA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
TELA Bio Market Cap Related Terms
TELA Bio Market Cap Historical Data
* Premium members only.
The historical data trend for TELA Bio's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, TELA Bio's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TELA Bio Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TELA Bio's Market Cap distribution charts can be found below:
* The bar in red indicates where TELA Bio's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
TELA Bio's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TELA Bio (TELA) has a Market Cap of $33.57 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on TELA Bio and its competitors. According to the industry distribution chart, TELA Bio ranks #598 out of 867 companies in the Medical Devices & Instruments industry, placing it in the top 69%.
Is TELA Bio's Market Cap too high?
TELA Bio's current Market Cap is $33.57 Mil. The Medical Devices & Instruments industry median Market Cap is 120.18. TELA Bio's value of $33.57 Mil is 72.1% below this industry median. Based on the distribution chart, TELA Bio ranks #598 out of 867 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, TELA Bio has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TELA Bio's Market Cap compare to NSPR and BDMD?
According to the Medical Devices & Instruments industry distribution chart, TELA Bio ranks #598 out of 867 companies for Market Cap. This places TELA Bio in the lower half of its industry. The industry median Market Cap is 120.18. TELA Bio's value of $33.57 Mil is 72.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 120.18, based on 867 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TELA Bio's current Market Cap of $33.57 Mil is 72.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on TELA Bio and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 120.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TELA Bio's current Market Cap is $33.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TELA Bio stock overvalued right now?
Based on GuruFocus' analysis, TELA Bio (TELA) is currently considered Possible Value Trap. The stock's GF Value™ is $1.67, compared to a current price of $0.75 — trading 55.1% below its estimated fair value. The current Market Cap is $33.57 Mil and 72.1% below the Medical Devices & Instruments industry median of 120.18. TELA Bio's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For TELA Bio (TELA), the current Market Cap is $33.57 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TELA Bio (TELA) Overvalued in 2026?
Based on GuruFocus' analysis, TELA Bio stock appears to be undervalued.
The current stock price of $0.75 is trading 55.1% below its estimated GF Value™ of $1.67.
GuruFocus considers TELA Bio to be Possible Value Trap.
Key valuation signals for TELA:
Market Cap: $33.57 Mil
GF Value™: $1.67 vs. price of $0.75 (55.1% below fair value)
Industry Position: 72.1% below the Medical Devices & Instruments median (#598 of 867)
No single metric tells the full story. See the TELA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
52GF Score
Get the complete analysis for TELA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TELA has been successfully added to your 
